483 Samsung Biologics Jun 2016

483 Samsung Biologics Jun 2016

Reyes Candau-Chacon FDA$119.00 - Available Now

FDA investigators audited the Samsung Biologics - Yeonsu-gu, Korea (the Republic of) facility and issued inspectional observations (via FDA 483) on 22 Jun 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 22 Jun 2016
  • Location: Yeonsu-gu, Korea (the Republic of)
  • FEI: 3010479596
Add To Cart